Clinical Trials Browser

Phase 4 × OTHER × Immunosuppressive Agents × Clear all

NCT03150134 2017-05-12

Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients

Phase 4 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute